1145PResponses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy. (23rd October 2018) - Naing, A; Autio, K A; Falchook, G S; Meric-Bernstam, F; Litton, J K; Ibrahim, N K; Hung, A; Oft, M; Leveque, J; Patel, M R